Metabolic syndrome is a cluster of conditions, increased blood pressure, a high blood sugar level, excess body fat around the waist and abnormal cholesterol levels that occur together, increasing your risk of heart disease, stroke and diabetes. It has been established that patients diagnosed with metabolic syndrome (MS) have significantly greater incidence of developing type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). Indeed, diabetes is a nationwide epidemic in the United States affecting nearly 26 million Americans, with 90-95% of these cases being T2DM. The monetary costs for diabetes alone accounts for an estimated 245 billion dollars in the United States annually. CVD is the primary cause of death in people with T2DM and ranks number one in fatalities worldwide. Similar to increased incidences of individuals with T2DM, diagnosis of people with MS is steadily rising.
Open access to the scientific literature means the removal of barriers (including price barriers) from accessing scholarly work. There are two parallel roads towards open access: Open Access articles and self-archiving. Open Access articles are immediately, freely available on their Web site, a model mostly funded by charges paid by the author (usually through a research grant). The alternative for a researcher is self-archiving (i.e., to publish in a traditional journal, where only subscribers have immediate access, but to make the article available on their personal and/or institutional Web sites (including so-called repositories or archives)), which is a practice allowed by many scholarly journals.
Open Access raises practical and policy questions for scholars, publishers, funders, and policymakers alike, including what the return on investment is when paying an article processing fee to publish in an Open Access articles, or whether investments into institutional repositories should be made and whether self-archiving should be made mandatory, as contemplated by some funders.
Last date updated on September, 2014